Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CIPROFLOXACIN Cause Neuropathy peripheral? 2,607 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 2,607 reports of Neuropathy peripheral have been filed in association with CIPROFLOXACIN (Ciprofloxacin). This represents 6.0% of all adverse event reports for CIPROFLOXACIN.

2,607
Reports of Neuropathy peripheral with CIPROFLOXACIN
6.0%
of all CIPROFLOXACIN reports
20
Deaths
418
Hospitalizations

How Dangerous Is Neuropathy peripheral From CIPROFLOXACIN?

Of the 2,607 reports, 20 (0.8%) resulted in death, 418 (16.0%) required hospitalization, and 88 (3.4%) were considered life-threatening.

Is Neuropathy peripheral Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CIPROFLOXACIN. However, 2,607 reports have been filed with the FAERS database.

What Other Side Effects Does CIPROFLOXACIN Cause?

Drug hypersensitivity (5,266) Arthralgia (3,749) Pain (3,201) Fatigue (3,056) Drug ineffective (2,918) Nausea (2,689) Diarrhoea (2,599) Pain in extremity (2,522) Dyspnoea (2,340) Anxiety (2,328)

What Other Drugs Cause Neuropathy peripheral?

LENALIDOMIDE (10,215) BORTEZOMIB (4,067) OXALIPLATIN (3,662) DEXAMETHASONE (3,543) PACLITAXEL (3,508) LEVOFLOXACIN (2,619) FLUOROURACIL (2,605) CYCLOPHOSPHAMIDE (2,565) POMALIDOMIDE (2,382) CAPECITABINE (2,202)

Which CIPROFLOXACIN Alternatives Have Lower Neuropathy peripheral Risk?

CIPROFLOXACIN vs CIPROFLOXACIN\DEXAMETHASONE CIPROFLOXACIN vs CIPROFLOXACIN\FLUOCINOLONE ACETONIDE CIPROFLOXACIN vs CISAPRIDE CIPROFLOXACIN vs CISATRACURIUM CIPROFLOXACIN vs CISPLATIN

Related Pages

CIPROFLOXACIN Full Profile All Neuropathy peripheral Reports All Drugs Causing Neuropathy peripheral CIPROFLOXACIN Demographics